Denali Therapeutics, Inc. (DNLI)
18.40
+0.40
(+2.22%)
USD |
NASDAQ |
Nov 18, 16:00
18.40
0.00 (0.00%)
After-Hours: 20:00
Denali Therapeutics Shareholders Equity (Quarterly) : 926.39M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 926.39M |
| June 30, 2026 | 835.18M |
| March 31, 2026 | 926.10M |
| December 31, 2025 | 1.014B |
| September 30, 2025 | 926.20M |
| June 30, 2025 | 1.027B |
| March 31, 2025 | 1.123B |
| December 31, 2024 | 1.230B |
| September 30, 2024 | 1.318B |
| June 30, 2024 | 1.387B |
| March 31, 2024 | 1.455B |
| December 31, 2023 | 1.031B |
| September 30, 2023 | 1.118B |
| June 30, 2023 | 1.187B |
| March 31, 2023 | 966.71M |
| December 31, 2022 | 1.042B |
| September 30, 2022 | 811.30M |
| June 30, 2022 | 884.45M |
| March 31, 2022 | 917.93M |
| December 31, 2021 | 962.29M |
| Date | Value |
|---|---|
| September 30, 2021 | 1.012B |
| June 30, 2021 | 1.073B |
| March 31, 2021 | 1.105B |
| December 31, 2020 | 1.151B |
| September 30, 2020 | 882.55M |
| June 30, 2020 | 502.17M |
| March 31, 2020 | 545.31M |
| December 31, 2019 | 394.89M |
| September 30, 2019 | 438.20M |
| June 30, 2019 | 475.17M |
| March 31, 2019 | 516.65M |
| December 31, 2018 | 546.84M |
| September 30, 2018 | 461.18M |
| June 30, 2018 | 490.27M |
| March 31, 2018 | 539.03M |
| December 31, 2017 | 465.80M |
| September 30, 2017 | 193.14M |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 254.52M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -7.503M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.529B |
| Anixa Biosciences, Inc. | 14.47M |
| Vicapsys Life Sciences, Inc. | -3.549M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.256B |
| Total Liabilities (Quarterly) | 329.65M |
| Debt to Equity Ratio | 0.038 |
| Current Ratio | 6.212 |
| Net Debt Paydown Yield | 0.07% |